Skip to Content

MYLAN 217 250 (Tolazamide 250 mg)

Pill with imprint MYLAN 217 250 is White, Round and has been identified as Tolazamide 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tolazamide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Tolazamide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 217 250

Tolazamide 250 mg MYLAN 217 250
Tolazamide 250 mg MYLAN 217 250 Front
Tolazamide 250 mg MYLAN 217 250 Back
Tolazamide 250 mg MYLAN 217 250

Tolazamide

Imprint:
MYLAN 217 250
Strength:
250 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00378-0217 Mylan Pharmaceuticals Inc.
68084-0556 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide